Liona Poon to Risk Assessment
This is a "connection" page, showing publications Liona Poon has written about Risk Assessment.
Connection Strength
0.054
-
Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history. Am J Obstet Gynecol. 2017 11; 217(5):585.e1-585.e5.
Score: 0.031
-
Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia. Am J Obstet Gynecol. 2017 12; 217(6):685.e1-685.e5.
Score: 0.008
-
Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations. Ultrasound Obstet Gynecol. 2017 Jun; 49(6):756-760.
Score: 0.008
-
Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation. Ultrasound Obstet Gynecol. 2017 Jun; 49(6):751-755.
Score: 0.008